Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANTI-INHIBITOR COAGULANT COMPLEX vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ANTI-INHIBITOR COAGULANT COMPLEX vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT: Safety Overview

Metric ANTI-INHIBITOR COAGULANT COMPLEX ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
Total FAERS Reports 1,437 10,586
Deaths Reported 273 367
Death Rate 19.0% 3.5%
Hospitalizations 284 2,090
Average Patient Age 34.3 yrs 27.3 yrs
% Female Patients 13.5% 3.0%
Manufacturer Takeda Pharmaceuticals America, Inc. N/A